Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Xi'an
Clinical trial register · China

Clinical Trials in Xi'an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Xi'an 46 Xi’an 5 Beijing 3 Chongqing 3 Changsha 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital123 Tang-Du Hospital50 First Affiliated Hospital Xi'an Jiaotong University41 Xijing Hospital of Digestive Diseases19 Air Force Military Medical University, China17 Yongquan Shi8 Pfizer6 Xidian University6 AbbVie6 Janssen Research & Development, LLC5 Xi'an No.3 Hospital5 The First Affiliated Hospital of Air Force Medical University5 Hoffmann-La Roche4 Peking University First Hospital4 Bristol-Myers Squibb4 Second Affiliated Hospital, Zhejiang University, School of Medicine4 The First Affiliated Hospital with Nanjing Medical University4 Xi'an Jiaotong University4 Amgen4 Northwest Women's and Children's Hospital, Xi'an, Shaanxi3 Shaanxi Normal University3 Xi'an International Medical Center Hospital3 Sun Yat-sen University3 xiaohua li3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 First Affiliated Hospital of Zhejiang University3 Edwards Lifesciences3 Second Affiliated Hospital of Xi'an Jiaotong University3 Shanghai Zhongshan Hospital3 Eli Lilly and Company3 Novartis Pharmaceuticals3 Peking University People's Hospital3 Xiamen Amoytop Biotech Co., Ltd.2 Hangzhou Sumgen Biotech Co., Ltd.2 Università Vita-Salute San Raffaele2 Peking University Third Hospital2 AstraZeneca2 Xiaoqin Luo2 Hepatopancreatobiliary Surgery Institute of Gansu Province2 RenJi Hospital2 West China Second University Hospital2 Takeda2 Akeso2 Zhejiang University2 Changhai Hospital2 Han Ying2 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 Abbott Medical Devices2 Shanghai Pharmaceuticals Holding Co., Ltd2 Ting Chang, MD2 Shanghai Henlius Biotech2 Guangzhou Women and Children's Medical Center1 LEO Pharma1 Beijing Children's Hospital1 Cytokinetics1 Yang Fan, MD1 National University of Singapore1 Xuanwu Hospital, Beijing1 Children's Hospital of Fudan University1 Harbin Medical University1 Xiaolong Yan, Dr.1 Actelion1 Ling Tao, MD, PhD1 University Hospital Tuebingen1 Myomed Technology (Shaoxing) Co., Ltd.1 Vifor Fresenius Medical Care Renal Pharma1 Chongqing Peg-Bio Biopharm Co., Ltd.1 Shanghai Escugen Biotechnology Co., Ltd1 Gracell Biotechnologies (Shanghai) Co., Ltd.1 Zuoyi Jiao1 IBSA Farmaceutici Italia Srl1 Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 Xingshun Qi1 Chinese University of Hong Kong1 Jing Han1 Fudan University1 Bambusa Therapeutics1 BioNTech SE1 BeiGene1 Shanghai StairMed Technology Co., Ltd.1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University1 Peking University International Hospital1 Fujian Shengdi Pharmaceutical Co., Ltd.1 Shuangyue Liu1 West China Hospital1 Third Military Medical University1 Abbisko Therapeutics Co, Ltd1 Eye & ENT Hospital of Fudan University1 GrandPharma (China) Co., Ltd.1 PharmaEssentia1 Qurgen Inc.1 Shanghai RAAS Blood Products Co., Ltd.1 magAssist, Inc.1 Peking University1 Genfleet Therapeutics (Shanghai) Inc.1 MAXVAX Biotechnology Limited Liability Company1 Merz North America, Inc.1 Wen-hong Zhang1 Boston Scientific Corporation1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 Genrix (Shanghai) Biopharmaceutical Co., Ltd.1 Danyang Huichuang Medical Equipment Co., Ltd.1 Universiti Sains Malaysia1 Shuhui Liang1 BeBetter Med Inc1 argenx1 Celgene1 Beijing Hospital1 Yan Xue1 Zhu Zijian1 Qilu Hospital of Shandong University1 Song Hongping1 Xi'an Honghui Hospital1 Changping Laboratory1 Shanghai Changzheng Hospital1 Beijing GoBroad Hospital1 Nutshell Therapeutics (Shanghai) Co., LTD.1 Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.1 Alexion Pharmaceuticals, Inc.1 Karuna Therapeutics, Inc., a Bristol Myers Squibb company1 BrosMed Medical Co., Ltd1 Wang Yusheng1 Min Shen1 Merck Sharp & Dohme LLC1 Yanbing Li1 Peking Union Medical College Hospital1 Nanfang Hospital, Southern Medical University1 Changchun GeneScience Pharmaceutical Co., Ltd.1 Jin Lu, MD1 Chipscreen Biosciences, Ltd.1 Beijing 302 Hospital1 Vigonvita Life Sciences1 Chinese PLA General Hospital1 Sichuan Huiyu Pharmaceutical Co., Ltd1 Chengdu New Radiomedicine Technology Co. LTD.1 Shanghai Xinzhi BioMed Co., Ltd.1 Biotech Pharmaceutical Co., Ltd.1 Sanofi1 Oneness Biotech Co., Ltd.1 Shenzhen Core Medical Technology CO.,LTD.1 Jie Liang1 Zhifeng Zhao, PhD1 Klus Pharma Inc.1 ChunBao Li1 HuaMg Perfection Med Tech (Suzhou) Co., Ltd.1 Second Affiliated Hospital of Soochow University1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Beijing Tongren Hospital1 First Affiliated Hospital of Fujian Medical University1 Beijing Anzhen Hospital1 Servier1 Guangdong Hengrui Pharmaceutical Co., Ltd1 Shaanxi Provincial People's Hospital1 Daiichi Sankyo1 Medtecx Co Ltd.1 Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.1 Shanghai NewMed Medical Co., Ltd.1 CASI pharmaceuticals, Inc.1 yilong Wang1 Ruijin Hospital1 Neuregen Therapeutics Co., Ltd.1 Beijing Northland Biotech. Co., Ltd.1 Zhengli Di1 Beijing Chest Hospital1 Genmab1 China-Japan Friendship Hospital1 Clear sponsor filter
Target enrolment
to

Trials with a site in Xi'an

50 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Tang-Du Hospital
Observational
500
Xi’an
2026-07-15
Recruiting
Tang-Du Hospital
Not applicable
500
Xi'an
2026-07-01
By invitation
Tang-Du Hospital
Observational
200
Beijing, Chongqing, Shenzhen, Wuhan, Nanjing, Shengyang, Qingdao, Xi’an
2026-06-18
Not yet open
Tang-Du Hospital
Not applicable
60
Xi'an
2026-06-15
Not yet open
Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial
NCT07699770Neuromyelitis Optica Spectrum Disorders (NMOSD), Neuropathic Pain
Tang-Du Hospital
Phase 4
110
Beijing, Chongqing, Harbin, Hohhot, Changchun, Shenyang, Xi'an, Ürümqi
2026-06-15
Not yet open
Tang-Du Hospital
Phase 2
33
Xi'an
2026-05-30
Recruiting
Tang-Du Hospital
Phase 2
60
Xi'an
2026-05-13
Recruiting
Tang-Du Hospital
Phase 2
90
Xi'an
2026-05-05
Not yet open
Tang-Du Hospital
Phase 1
30
Xi'an
2026-05-01
Not yet open
Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer
NCT07538193Carcinoma, Non-Small-Cell Lung (NSCLC), Neoplasm Staging, Lymphatic Metastasis
Tang-Du Hospital
Not applicable
28
Xi'an
2026-05
Recruiting
Intra-arterial Methylprednisolone After Endovascular Thrombectomy
NCT07516522Ischemia Stroke, Thrombectomy, Large Vessel Occlusion
Tang-Du Hospital
Phase 2
210
Xi'an
2026-03-31
Recruiting
Tang-Du Hospital
Phase 1/2
20
Xi’an
2026-03-25
Recruiting
Tang-Du Hospital
Phase 1/2
45
Xi'an
2026-01-28
Recruiting
Tang-Du Hospital
Not applicable
192
Xi'an
2026-01-21
Recruiting
Tang-Du Hospital
Not applicable
174
Xi'an
2026-01-01
Recruiting
Anxiety and Depression in IBS: A Brain-Gut Axis Study
NCT07646834Irritable Bowel Syndrome (IBS), Anxiety, Depression
Tang-Du Hospital
Observational
200
Xi'an
2025-12-21
Recruiting
Tang-Du Hospital
Not applicable
12
Xi'an
2025-12-08
Recruiting
Tang-Du Hospital
Observational
300
Xi'an
2025-09-01
Recruiting
Tang-Du Hospital
Phase 2
32
Xi'an
2025-08-25
Recruiting
Tang-Du Hospital
Phase 3
1,060
Xi'an
2025-08-08
Recruiting
Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.
NCT07092423Traumatic Brain Injury, Neurocritical Care, Enteral Feeding Intolerance
Tang-Du Hospital
Not applicable
100
Xi'an
2025-05-18
Not yet open
Tang-Du Hospital
Not applicable
20
Xi'an
2025-05
Recruiting
Evaluating Mechanically Engineered Stem Cell Exosomes for Treating Endometrial Injury: A Clinical Study
NCT06896747Thin Endometrial Lining, Female Infertility, Intrauterine Adhesions
Tang-Du Hospital
Phase 1/2
90
Xi'an
2025-02-21
Recruiting
Tang-Du Hospital
Phase 2
27
Changsha, Yinchuan, Xi'an
2025-02-18
Recruiting
Tang-Du Hospital
Phase 2
80
Xi'an
2024-10-01
Recruiting
Tang-Du Hospital
Not applicable
96
Wuhan, Nanjing, Shenyang, Xi'an, Chengdu, Ürümqi, Chongqing, Shanghai
2024-09-01
Recruiting
Tang-Du Hospital
Phase 2
104
Xi'an
2024-07-01
Not yet open
Tang-Du Hospital
Phase 2
178
Xi'an
2024-06-30
Recruiting
Tang-Du Hospital
Phase 2
60
Xi'an
2024-06-20
Recruiting
Tang-Du Hospital
Not applicable
60
Xi'an
2024-05-01
Recruiting
Tang-Du Hospital
Phase 4
24
Xi'an
2024-03-15
Recruiting
Tang-Du Hospital
Phase 2
100
Xi'an
2023-11-24
Recruiting
Tang-Du Hospital
Phase 2
20
Xi'an
2023-10-09
Active, closed
fMRI Study of the Neural Mechanism of rTMS in the Treatment of Nicotine Dependence
NCT06762535Tobacco Use Disorder, Repetitive Transcranial Magnetic Stimulation
Tang-Du Hospital
Not applicable
50
Xi'an
2023-04-01
Active, closed
Tang-Du Hospital
Phase 2
40
Xi'an
2023-01-10
Recruiting
Tang-Du Hospital
Observational
300
Xi'an
2023-01-01
Active, closed
Tang-Du Hospital
Not applicable
30
Xi'an
2022-08-01
Recruiting
Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
NCT06006650Neoadjuvent, PD-1 Inhibitor, Chemotherapy, Esophageal Squamous Cell Carcinoma
Tang-Du Hospital
Phase 2
114
Xi'an, Xi’an
2022-08-01
Recruiting
Tang-Du Hospital
Phase 2
64
Beijing, Changsha, Xi'an, Shanghai, Chengdu, Tianjin
2022-07-21
Recruiting
Ofatumumab in AQP4-IgG Seropositive NMOSD
NCT05504694Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital
Phase 1/2
5
Xi'an
2022-06-28
Recruiting
Assessment of Brain Cognitive Impairment in Breast Cancer
NCT05305092Breast Cancer, Chemo-brain, Endocrine Therapy
Tang-Du Hospital
Observational
90
Xi'an
2022-05-31
Not yet open
Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH
NCT05043181Familial Hypercholesterolemia
Tang-Du Hospital
Phase 1
30
Xi'an
2021-12
Recruiting
Intracranial Pressure Monitoring in Moderate Traumatic Brain Injury
NCT04900168Moderate Traumatic Brain Injury
Tang-Du Hospital
Observational
1,000
Xi'an
2021-06-01
Active, closed
Tang-Du Hospital
Phase 2
45
Xi'an
2021-03-01
Recruiting
Assess the Risk of Cerebrovascular Disease
NCT04443439Cerebrovascular Disease
Tang-Du Hospital
Observational
100
Xi'an
2020-10-09
Recruiting
Tang-Du Hospital
Observational
200
Xi'an
2019-11-04
Recruiting
The Early Warning System for the Diabetic Encephalopathy
NCT02420470Diabetes Mellitus Type 2, Mild Cognitive Impairment, Metabolic Syndrome X
Tang-Du Hospital
Observational
300
Xi'an
2015-04
Rows per page Showing 1–50 of 50
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 50 of those studies with a site in Xi'an that also match the filters currently applied.

How many clinical trials are recruiting in Xi'an?

33 of the 50 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 12 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xi'an), 50 studies
PhaseStudiesRecruitingShare
Phase 2181236%
Not applicable12724%
Observational10820%
Phase 1/2448%
Phase 1204%
Phase 3214%
Phase 4214%

Most active sponsors

Lead sponsors with the most studies (Xi'an)
Lead sponsorStudiesRecruiting
Tang-Du Hospital5033
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.